Dolo Infusion I.V 100 ml

babies: it is not applied to babies. lactating mothers: it is safe.
studies have shown that medicine has no risk for the baby as it is released in small amounts in breast milk. pregnancy: it is safe in pregnancy.
however, it should be used at the lowest effective dose for the shortest time and the lowest frequency possible. driving: this medication does not affect the ability to drive.
alcohol: avoid alcohol consumption while taking dolo injection as it may cause an increased risk of liver failure. liver: dolo injection should be used in caution with patients suffering from liver disease.
you may require a dose adjustment and regular monitoring of liver function. seek doctor advice before using this medication.
kidney: dolo injection should be used in caution with patients suffering from kidney disease. you may require a dose adjustment and regular monitoring of kidney function.
seek doctor advice before using this medication..

nausea vomiting constipation rash itching stomach ulcers fatigue dizziness hepatotoxicity nephrotoxicity stevens johnson syndrome.

dolo injection is an antipyretic and analgesic. it works by acting on the hypothalamus to produce antipyresis.
it is possible to work peripherally to inhibit pain impulse generation. it also inhibits prostaglandin synthesis in the cns.
.

consult your doctor immediately if you missed the dose of dolo injection..

• inform your doctor if you are also taking any other dolo-containing medications. • inform your doctor if you have severe kidney disease or liver disease. • you should avoid drinking alcohol while using this medication..

serious • dolo + imatinib: concurrent use may lead to increased concentrations of dolo by inhibiting its metabolism • dolo + isoniazid: concurrent use may lead to increased risk of hepatotoxicity • dolo + pneumonococcal 13-variant, diptheria conjugate: concurrent use may lead to an inadequate immunologic response to the vaccine monitor closely • dolo + acenocoumarol: concurrent use may lead to potentiation of anticoagulant effect by inhibiting acenocoumarol metabolism • dolo + busalfan: concurrent use may lead to decreased busulfan renal clearance • dolo + carbamazepine: concurrent use may lead to increased risk of dolo hepatotoxicity by increased dolo metabolism • dolo + warfarin: concurrent use may lead to increased risk of bleeding minor • dolo + chloramphenicol: concurrent use may lead to increased risk of chloramphenicol toxicity • dolo + cholestyramine: concurrent use may lead to decreased dolo effectiveness by decreased absorption of dolo • dolo + fenoldopam: concurrent use may lead to increased fenoldopam concentrations.